Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ADMA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
43 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
322 filers reported a long position in ADMA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $321M | 38.4M | +4.1% |
| STATE STREET CORP | $143.3M | 17.1M | +21.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.6M | 10.1M | -2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $84.4M | 10.1M | +13.8% |
| Rubric Capital Management LP | $78.2M | 9.3M | +416.2% |
| Capital Research Global Investors | $73.3M | 8.8M | -21.8% |
| FIRST TRUST ADVISORS LP | $65.3M | 7.8M | +2,064.9% |
| GEODE CAPITAL MANAGEMENT, LLC | $50.7M | 6.1M | +4% |
| Caligan Partners LP | $47.9M | 5.7M | +20.4% |
| D. E. Shaw & Co., Inc. | $44.1M | 5.3M | +840.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.